© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Nuclear factor 
B: a potential therapeutic target in atherosclerosis and thrombosis
Faculty of Medicine, Kennedy Institute of Rheumatology, Imperial College, Arthritis Research Campaign Building, 1, Aspenlea Road, London W6 8LH, UK
* Corresponding author. Tel.: +44-20-8383-4481; fax: +44-20-8383-4499. e.paleolog{at}imperial.ac.uk
Cardiovascular diseases are the leading cause of morbidity and mortality in Western countries. Atherosclerosis, the background for many cardiovascular diseases, is characterized by the accumulation of lipid and fibrotic entities in large arteries and bears many similarities with chronic inflammatory diseases such as rheumatoid arthritis. Common features include extravasation of blood-derived leukocytes, as well as production of cytokines, chemokines and matrix-degrading enzymes. There are also many shared signaling pathways, including activation of the nuclear factor 
B (NFB) cascade. In the context of atherosclerosis, there are a range of candidate stimuli which can activate NFB, including traditional risk factors, infectious agents, cytokines and cell–cell contact. Many inflammatory genes relevant to the pathogenesis of atherosclerosis are regulated by NFB, the activated form of which is present in atherosclerotic plaques. Thus, it is essential to understand the role of this important signaling cascade in atherosclerosis, in a quest for more specific therapeutic targets.
KEYWORDS Atherosclerosis; Thrombosis; Inflammation; NFB
Time for primary review 32 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Largo, M. J. Martinez-Calatrava, O. Sanchez-Pernaute, M. E. Marcos, J. Moreno-Rubio, C. Aparicio, J. Egido, and G. Herrero-Beaumont Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H268 - H276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. You, Y.-Y. Jiang, S. Chen, G. Yan, and J. Sun The Orphan Nuclear Receptor Nur77 Suppresses Endothelial Cell Activation Through Induction of I{kappa}B{alpha} Expression Circ. Res., March 27, 2009; 104(6): 742 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2399 - H2408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chen, H. Chai, X. Wang, J. Jiang, M. S. Jamaluddin, D. Liao, Y. Zhang, H. Wang, U. Bharadwaj, S. Zhang, et al. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells Blood, October 15, 2008; 112(8): 3205 - 3216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shen, E. Oesterling, A. Stromberg, M. Toborek, R. MacDonald, and B. Hennig Zinc Deficiency Induces Vascular Pro-Inflammatory Parameters Associated with NF-{kappa}B and PPAR Signaling J. Am. Coll. Nutr., October 1, 2008; 27(5): 577 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Werner, J. D. Kearns, V. Zadorozhnaya, C. Lynch, E. O'Dea, M. P. Boldin, A. Ma, D. Baltimore, and A. Hoffmann Encoding NF-{kappa}B temporal control in response to TNF: distinct roles for the negative regulators I{kappa}B{alpha} and A20 Genes & Dev., August 1, 2008; 22(15): 2093 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chen, M. S. Jamaluddin, S. Yan, D. Sheikh-Hamad, and Q. Yao Human Stanniocalcin-1 Blocks TNF-{alpha}-Induced Monolayer Permeability in Human Coronary Artery Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 906 - 912. [Abstract] [Full Text] [PDF]
|
|